Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Intercept announces FDA pre-submission meeting for NASH NDA moved to July » 06:38
06/06/22
06/06
06:38
06/06/22
06:38
ICPT

Intercept

$16.39 /

-1.245 (-7.06%)

Intercept Pharmaceuticals…

Intercept Pharmaceuticals announced an update on the timing of its pre-submission meeting with the U.S. Food and Drug Administration regarding the potential resubmission of its nonalcoholic steatohepatitis New Drug Application based on an interim analysis of the REGENERATE trial in patients with fibrosis due to NASH. The pre-submission meeting, previously scheduled in June, has been moved to July following a recent request from the FDA that topline data from REGENERATE be provided to the agency for its review prior to the meeting. Intercept anticipates that topline data from REGENERATE will be available and made public in July.

ShowHide Related Items >><<
ICPT Intercept
$16.39 /

-1.245 (-7.06%)

ICPT Intercept
$16.39 /

-1.245 (-7.06%)

05/10/22 B. Riley
Intercept price target raised to $32 from $30 at B. Riley
05/09/22 Raymond James
Intercept price target lowered to $23 from $44 at Raymond James
05/06/22 Piper Sandler
Piper Sandler remains bullish on Intercept with $82 target
03/08/22 Canaccord
Intercept price target lowered to $29 from $31 at Canaccord
ICPT Intercept
$16.39 /

-1.245 (-7.06%)

ICPT Intercept
$16.39 /

-1.245 (-7.06%)

Over a month ago
Hot Stocks
Intercept announces results from two studies evaluating Ocaliva » 07:33
06/03/22
06/03
07:33
06/03/22
07:33
ICPT

Intercept

$17.64 /

-0.195 (-1.09%)

Intercept Pharmaceuticals…

Intercept Pharmaceuticals announced results from two studies designed to evaluate clinical outcomes in patients with PBC on Ocaliva: COBALT, a Phase 3b/4 confirmatory clinical outcomes study, and HEROES-US, one of two HEROES real-world studies. Findings from these studies will be part of a broader evidence package being submitted to the U.S. Food and Drug Administration, FDA, in the second half of 2022. In 2021, Intercept announced COBALT would be terminated early as a result of conversations with regulatory authorities and guidance from the study's data monitoring committee, DMC. The DMC noted that the objectives of the trial were not feasible given the inherent challenges with enrolling and maintaining patients in a placebo-controlled study in a rare disease when the study drug is commercially available. COBALT Study Results: In COBALT, patients were randomized 1:1 to Ocaliva or placebo. The primary endpoint, as agreed with the FDA, was time to first occurrence of any of the following clinical endpoints: all-cause death, liver transplant, or hospitalization for other serious liver-related events. The study did not demonstrate a statistically significant difference between Ocaliva and placebo on the primary endpoint: 71 subjects in the Ocaliva arm progressed to clinical events compared to 80 in the placebo arm. The safety and tolerability of Ocaliva were consistent with its known profile; adverse events were in line with expectations for patients with advanced PBC based on the natural history of the disease. At the time of the early termination, COBALT was less than 80% enrolled. More than 50% of patients discontinued the study prior to meeting the study endpoint. In addition, at least 14% of patients on placebo initiated commercially available Ocaliva during the study but remained in the placebo arm for reporting purposes. HEROES-US Study Results: The HEROES-US retrospective real-world analysis leveraged Komodo Health, a U.S. claims database, to compare clinical outcomes in a pre-defined group of patients with PBC who were treated with Ocaliva and a comparable group of PBC patients who were eligible, but who were not treated with Ocaliva. The study showed a statistically significant and clinically meaningful reduction in all-cause death, liver transplant, or hospitalization for hepatic decompensation among Ocaliva-treated patients compared to the control group. Thus, individuals with PBC who received Ocaliva had a 62% reduction in risk of all-cause death, liver transplant or hospitalization for hepatic decompensation than the control groups at any time during follow up.

ShowHide Related Items >><<
ICPT Intercept
$17.64 /

-0.195 (-1.09%)

ICPT Intercept
$17.64 /

-0.195 (-1.09%)

05/10/22 B. Riley
Intercept price target raised to $32 from $30 at B. Riley
05/09/22 Raymond James
Intercept price target lowered to $23 from $44 at Raymond James
05/06/22 Piper Sandler
Piper Sandler remains bullish on Intercept with $82 target
03/08/22 Canaccord
Intercept price target lowered to $29 from $31 at Canaccord
ICPT Intercept
$17.64 /

-0.195 (-1.09%)

ICPT Intercept
$17.64 /

-0.195 (-1.09%)

Hot Stocks
Intercept announces first patient dosed oin Phase 2 OCA, bezafibrate trial » 08:12
05/11/22
05/11
08:12
05/11/22
08:12
ICPT

Intercept

$18.78 /

+0.735 (+4.07%)

Intercept Pharmaceuticals…

Intercept Pharmaceuticals announced the first patient has been dosed in a Phase 2 study evaluating a fixed-dose combination of obeticholic acid and bezafibrate for the treatment of patients with primary biliary cholangitis who have not achieved an adequate biochemical response to ursodeoxycholic acid. The double-blind, randomized, active controlled, parallel group study will evaluate the reduction in alkaline phosphatase over 12 weeks, followed by a long-term safety extension. The reduction in ALP has been accepted by regulators as part of a composite surrogate endpoint for investigational agents in PBC. Secondary endpoints include safety and tolerability, and other biochemical markers of disease progression: aspartate aminotransferase, gamma-glutamyl transferase, alanine aminotransferase and bilirubin. The study is expected to recruit approximately 60 patients, primarily in the U.S., across four treatment arms. A second Phase 2 study, currently active in Europe, is evaluating different dosing regimens of the OCA-BZF combination. A large Phase 1 study is ongoing in the U.S., testing multiple different dose combinations in healthy adult subjects. Once complete, these three complementary studies will inform dose selection and study design for a Phase 3 trial.

ShowHide Related Items >><<
ICPT Intercept
$18.78 /

+0.735 (+4.07%)

ICPT Intercept
$18.78 /

+0.735 (+4.07%)

05/10/22 B. Riley
Intercept price target raised to $32 from $30 at B. Riley
05/09/22 Raymond James
Intercept price target lowered to $23 from $44 at Raymond James
05/06/22 Piper Sandler
Piper Sandler remains bullish on Intercept with $82 target
03/08/22 Canaccord
Intercept price target lowered to $29 from $31 at Canaccord
ICPT Intercept
$18.78 /

+0.735 (+4.07%)

ICPT Intercept
$18.78 /

+0.735 (+4.07%)

Recommendations
Intercept price target raised to $32 from $30 at B. Riley » 07:56
05/10/22
05/10
07:56
05/10/22
07:56
ICPT

Intercept

$18.05 /

-1.14 (-5.94%)

B. Riley analyst Mayank…

B. Riley analyst Mayank Mamtani raised the firm's price target on Intercept t Pharmaceuticals to $32 from $30 and keeps a Buy rating on the shares post the Q1 results. The analyst says the Advanz transaction strengthens the balance sheet and enables Intercept to focus on its "appropriate strategic positioning."

ShowHide Related Items >><<
ICPT Intercept
$18.05 /

-1.14 (-5.94%)

ICPT Intercept
$18.05 /

-1.14 (-5.94%)

05/09/22 Raymond James
Intercept price target lowered to $23 from $44 at Raymond James
05/06/22 Piper Sandler
Piper Sandler remains bullish on Intercept with $82 target
03/08/22 Canaccord
Intercept price target lowered to $29 from $31 at Canaccord
01/11/22 B. Riley
B. Riley upgrades Intercept into 'catalyst rich' first half of 2022
ICPT Intercept
$18.05 /

-1.14 (-5.94%)

ICPT Intercept
$18.05 /

-1.14 (-5.94%)

Recommendations
Intercept price target lowered to $23 from $44 at Raymond James » 07:25
05/09/22
05/09
07:25
05/09/22
07:25
ICPT

Intercept

$19.22 /

-0.245 (-1.26%)

Raymond James analyst…

Raymond James analyst Steven Seedhouse lowered the firm's price target on Intercept to $23 from $44 and keeps an Outperform rating on the shares. Ocaliva has a "decent" chance of about 60% approval in F2/F3 NASH, Seedhouse tells investors in a research note.

ShowHide Related Items >><<
ICPT Intercept
$19.22 /

-0.245 (-1.26%)

ICPT Intercept
$19.22 /

-0.245 (-1.26%)

05/06/22 Piper Sandler
Piper Sandler remains bullish on Intercept with $82 target
03/08/22 Canaccord
Intercept price target lowered to $29 from $31 at Canaccord
01/11/22 B. Riley
B. Riley upgrades Intercept into 'catalyst rich' first half of 2022
01/10/22 B. Riley
Intercept upgraded to Buy from Neutral at B. Riley
ICPT Intercept
$19.22 /

-0.245 (-1.26%)

ICPT Intercept
$19.22 /

-0.245 (-1.26%)

Recommendations
Piper Sandler remains bullish on Intercept with $82 target » 12:48
05/06/22
05/06
12:48
05/06/22
12:48
ICPT

Intercept

$19.08 /

-0.385 (-1.98%)

Piper Sandler analyst…

Piper Sandler analyst Yasmeen Rahimi continues to be bullish on Intercept Pharmaceuticals post the Q1 results and heading into topline REGENERATE re-analysis data on track for Q2. With the recent Advanz Pharma licensing deal, the $405M upfront cash "provides optionality" to Intercept, Rahimi tells investors in a research note. The analyst keeps an Overweight rating on the shares with an $82 price target

ShowHide Related Items >><<
ICPT Intercept
$19.08 /

-0.385 (-1.98%)

ICPT Intercept
$19.08 /

-0.385 (-1.98%)

03/08/22 Canaccord
Intercept price target lowered to $29 from $31 at Canaccord
01/11/22 B. Riley
B. Riley upgrades Intercept into 'catalyst rich' first half of 2022
01/10/22 B. Riley
Intercept upgraded to Buy from Neutral at B. Riley
12/20/21 H.C. Wainwright
Intercept delay for NASH data not due to adverse findings, says H.C. Wainwright
ICPT Intercept
$19.08 /

-0.385 (-1.98%)

ICPT Intercept
$19.08 /

-0.385 (-1.98%)

Earnings
Intercept reports Q1 EPS (58c), consensus (91c) » 07:03
05/06/22
05/06
07:03
05/06/22
07:03
ICPT

Intercept

$19.48 /

+3.28 (+20.25%)

Reports Q1 revenue…

Reports Q1 revenue $88.58M, consensus $90.49M. "Our team made considerable progress in the first quarter of this year as we continued to drive the growth of Ocaliva in PBC, worked toward delivering data analyses from our Phase 3 REGENERATE and REVERSE studies in NASH, and advanced our pipeline programs," said Jerry Durso, President and Chief Executive Officer of Intercept. "In the near-term, we are focused on preparing for new topline data from REGENERATE and conducting a pre-submission meeting with FDA later this quarter," Durso continued. "Importantly, our recent agreement with Advanz Pharma to license Ocaliva for PBC outside the U.S. significantly strengthens our balance sheet, providing us with greater financial flexibility and strategic optionality during this transformational time."

ShowHide Related Items >><<
ICPT Intercept
$19.48 /

+3.28 (+20.25%)

ICPT Intercept
$19.48 /

+3.28 (+20.25%)

03/08/22 Canaccord
Intercept price target lowered to $29 from $31 at Canaccord
01/11/22 B. Riley
B. Riley upgrades Intercept into 'catalyst rich' first half of 2022
01/10/22 B. Riley
Intercept upgraded to Buy from Neutral at B. Riley
12/20/21 H.C. Wainwright
Intercept delay for NASH data not due to adverse findings, says H.C. Wainwright
ICPT Intercept
$19.48 /

+3.28 (+20.25%)

ICPT Intercept
$19.48 /

+3.28 (+20.25%)

On The Fly
What You Missed On Wall Street On Thursday » 16:41
05/05/22
05/05
16:41
05/05/22
16:41
TWTR

Twitter

$50.44 /

+1.34 (+2.73%)

, TSLA

Tesla

$873.41 /

-79.31 (-8.32%)

, SGLY

Singularity Future Technology

$4.80 /

-1.96 (-28.99%)

, ZETA

Zeta Global

$8.64 /

-1.765 (-16.97%)

, BLCO

Bausch + Lomb

/

+

, BHC

Bausch Health

$16.76 /

-1.345 (-7.43%)

, VIVHY

Vivendi

$11.58 /

-0.47 (-3.90%)

, LGF.A

Lionsgate

$13.49 /

-0.39 (-2.81%)

, LGF.B

Lionsgate

$12.51 /

-0.39 (-3.02%)

, BKNG

Booking Holdings

$2,173.00 /

+78.65 (+3.76%)

, EBAY

eBay

$48.05 /

-6.37 (-11.71%)

, SHOP

Shopify

$413.51 /

-72.105 (-14.85%)

, CNC

Centene

$84.71 /

+1.84 (+2.22%)

, SIMO

Silicon Motion

$95.08 /

+13.9602 (+17.21%)

, MXL

MaxLinear

$44.55 /

-9.04 (-16.87%)

, FTNT

Fortinet

$285.32 /

-1.02 (-0.36%)

, SFM

Sprouts Farmers Market

$23.74 /

-7.665 (-24.41%)

, EAT

Brinker

$34.60 /

-0.04 (-0.12%)

, TUP

Tupperware Brands

$10.60 /

-1.555 (-12.79%)

, CMLS

Cumulus Media

$15.38 /

+1.17 (+8.23%)

, ICPT

Intercept

$19.48 /

+3.28 (+20.25%)

, SLQT

SelectQuote

$2.61 /

+0.2 (+8.30%)

, HDSN

Hudson Technologies

$9.05 /

+1.925 (+27.02%)

, LICY

Li-Cycle

$7.75 /

+0.565 (+7.86%)

, GLNCY

Glencore

$11.95 /

-0.45 (-3.63%)

, FSLY

Fastly

$13.80 /

-3.01 (-17.91%)

, INSG

Inseego

$2.31 /

-0.75 (-24.55%)

, ETSY

Etsy

$90.93 /

-18.735 (-17.08%)

, CROX

Crocs

$65.62 /

-6.64 (-9.19%)

, TWLO

Twilio

$116.84 /

-1.68 (-1.42%)

, W

Wayfair

$67.42 /

-23.26 (-25.65%)

, K

Kellogg

$70.24 /

+2.39 (+3.52%)

Get caught up quickly on…

ShowHide Related Items >><<
ZETA Zeta Global
$8.64 /

-1.765 (-16.97%)

W Wayfair
$67.42 /

-23.26 (-25.65%)

VIVHY Vivendi
$11.58 /

-0.47 (-3.90%)

TWTR Twitter
$50.44 /

+1.34 (+2.73%)

TWLO Twilio
$116.84 /

-1.68 (-1.42%)

TUP Tupperware Brands
$10.60 /

-1.555 (-12.79%)

TSLA Tesla
$873.41 /

-79.31 (-8.32%)

SLQT SelectQuote
$2.61 /

+0.2 (+8.30%)

SIMO Silicon Motion
$95.08 /

+13.9602 (+17.21%)

SHOP Shopify
$413.51 /

-72.105 (-14.85%)

SGLY Singularity Future Technology
$4.80 /

-1.96 (-28.99%)

SFM Sprouts Farmers Market
$23.74 /

-7.665 (-24.41%)

MXL MaxLinear
$44.55 /

-9.04 (-16.87%)

LICY Li-Cycle
$7.75 /

+0.565 (+7.86%)

LGF.A Lionsgate
$13.49 /

-0.39 (-2.81%)

K Kellogg
$70.24 /

+2.39 (+3.52%)

ICPT Intercept
$19.48 /

+3.28 (+20.25%)

HDSN Hudson Technologies
$9.05 /

+1.925 (+27.02%)

GLNCY Glencore
$11.95 /

-0.45 (-3.63%)

FTNT Fortinet
$285.32 /

-1.02 (-0.36%)

FSLY Fastly
$13.80 /

-3.01 (-17.91%)

ETSY Etsy
$90.93 /

-18.735 (-17.08%)

EBAY eBay
$48.05 /

-6.37 (-11.71%)

EAT Brinker
$34.60 /

-0.04 (-0.12%)

CROX Crocs
$65.62 /

-6.64 (-9.19%)

CNC Centene
$84.71 /

+1.84 (+2.22%)

CMLS Cumulus Media
$15.38 /

+1.17 (+8.23%)

BLCO Bausch + Lomb
/

+

BKNG Booking Holdings
$2,173.00 /

+78.65 (+3.76%)

BHC Bausch Health
$16.76 /

-1.345 (-7.43%)

TWTR Twitter
$50.44 /

+1.34 (+2.73%)

05/05/22 Argus
Twitter downgraded to Hold at Argus after board approves Musk buyout
05/05/22 Argus
Twitter downgraded to Hold from Buy at Argus
04/29/22 Evercore ISI
Evercore 'impressed' by Snap's product innovation after partner summit
04/28/22 Piper Sandler
Twitter price target raised to $51.50 from $46 at Piper Sandler
TSLA Tesla
$873.41 /

-79.31 (-8.32%)

04/27/22 Wedbush
Twitter transaction 'was never ideal' for Tesla investors, says Wedbush
04/26/22 Wedbush
'Soap opera' now ends with Musk owning Twitter, says Wedbush
04/25/22 Gordon Haskett
Twitter bid more attractive after market selloff, says Gordon Haskett
04/25/22 Wedbush
Twitter bid unlikely to result in major sale of Musk's Tesla stock, says Wedbush
SGLY Singularity Future Technology
$4.80 /

-1.96 (-28.99%)

ZETA Zeta Global
$8.64 /

-1.765 (-16.97%)

04/07/22 Oppenheimer
Zeta Global upgraded to Outperform from Perform at Oppenheimer
02/07/22 Craig-Hallum
Craig-Hallum bullish on Zeta Global, initiates with a Buy
02/07/22 Craig-Hallum
Zeta Global initiated with a Buy at Craig-Hallum
11/16/21 Credit Suisse
Zeta Global initiated with a Neutral at Credit Suisse
BLCO Bausch + Lomb
/

+

BHC Bausch Health
$16.76 /

-1.345 (-7.43%)

02/01/22 RBC Capital
Bausch Health price target lowered to $34 from $40 at RBC Capital
11/03/21 JPMorgan
Bausch Health earnings selloff a buying opportunity, says JPMorgan
09/21/21 JPMorgan
Bausch has 50% upside based on sum-of-the-parts, says JPMorgan
08/04/21 JPMorgan
Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
VIVHY Vivendi
$11.58 /

-0.47 (-3.90%)

04/26/22 Credit Suisse
Vivendi price target raised to EUR 13.10 from EUR 13 at Credit Suisse
04/25/22 JPMorgan
Vivendi price target raised to EUR 13.60 from EUR 13.30 at JPMorgan
04/11/22 Credit Suisse
Vivendi price target raised to EUR 13.10 from EUR 13 at Credit Suisse
03/16/22 Deutsche Bank
Vivendi price target lowered to EUR 14 from EUR 15 at Deutsche Bank
LGF.A Lionsgate
$13.49 /

-0.39 (-2.81%)

04/19/22 Rosenblatt
Lionsgate initiated with a Buy at Rosenblatt
02/07/22 Cowen
Lionsgate price target lowered to $17 from $21 at Cowen
01/31/22 Truist
Lionsgate price target raised to $18 from $16 at Truist
01/04/22 Wells Fargo
Lionsgate upgraded to Overweight from Equal Weight at Wells Fargo
LGF.B Lionsgate
$12.51 /

-0.39 (-3.02%)

01/04/22 Wells Fargo
Wells Fargo upgrades Lionsgate to Overweight, raises price target to $25
BKNG Booking Holdings
$2,173.00 /

+78.65 (+3.76%)

05/05/22 Piper Sandler
Booking Holdings price target raised to $2,500 from $2,440 at Piper Sandler
05/05/22 RBC Capital
Booking Holdings price target raised to $2,800 from $2,700 at RBC Capital
05/05/22 Evercore ISI
Booking Holdings price target raised to $3,000 from $2,900 at Evercore ISI
05/05/22 Credit Suisse
Booking Holdings price target raised to $2,985 from $2,850 at Credit Suisse
EBAY eBay
$48.05 /

-6.37 (-11.71%)

05/05/22 Baird
eBay price target lowered to $65 from $80 at Baird
05/05/22 Stifel
eBay price target lowered to $62 from $70 at Stifel
05/05/22 Benchmark
eBay price target lowered to $67 from $71 at Benchmark
05/05/22 Deutsche Bank
eBay price target lowered to $60 from $64 at Deutsche Bank
SHOP Shopify
$413.51 /

-72.105 (-14.85%)

05/05/22 Jefferies
Shopify price target lowered to $550 from $1,350 at Jefferies
05/05/22 Oppenheimer
Shopify price target lowered to $500 from $960 at Oppenheimer
05/05/22 Jefferies
Shopify Q1 results 'worse than feared,' says Jefferies
05/05/22 Veritas
Shopify downgraded to Sell from Buy at Veritas (yesterday)
CNC Centene
$84.71 /

+1.84 (+2.22%)

03/29/22 Deutsche Bank
CVS Health downgraded to Hold from Buy at Deutsche Bank
03/23/22 BTIG
Exagen price target lowered to $15 from $20 at BTIG
03/23/22 Jefferies
Centene CEO pick may spur some negative stock reaction, says Jefferies
02/09/22 Deutsche Bank
Centene price target raised to $88 from $84 at Deutsche Bank
SIMO Silicon Motion
$95.08 /

+13.9602 (+17.21%)

05/05/22 Deutsche Bank
MaxLinear upgraded to Buy at Deutsche Bank, see opportunity in selloff
05/05/22 Susquehanna
Silicon Motion downgraded to Neutral from Positive at Susquehanna
05/05/22 Wedbush
Wedbush sees 'attractive opportunity' in Silicon Motion
05/05/22 Craig-Hallum
Silicon Motion could see 'bidding war,' says Craig-Hallum
MXL MaxLinear
$44.55 /

-9.04 (-16.87%)

05/05/22 Deutsche Bank
MaxLinear upgraded to Buy from Hold at Deutsche Bank
FTNT Fortinet
$285.32 /

-1.02 (-0.36%)

05/05/22 Wedbush
Fortinet price target lowered to $340 from $370 at Wedbush
05/05/22 Deutsche Bank
Fortinet price target raised to $320 from $250 at Deutsche Bank
05/05/22 Wells Fargo
Fortinet price target raised to $400 from $360 at Wells Fargo
05/05/22 Mizuho
Fortinet upgraded to Buy after 'very good' quarter at Mizuho
SFM Sprouts Farmers Market
$23.74 /

-7.665 (-24.41%)

05/05/22 BofA
BofA double downgrades Sprouts to sell on price hikes, inflation
05/05/22 BofA
Sprouts Farmers Market downgraded to Underperform from Buy at BofA
04/29/22 BofA
Sprouts Farmers Market double upgraded to Buy at BofA on EPS upside
04/29/22 BofA
Sprouts Farmers Market upgraded to Buy from Underperform at BofA
EAT Brinker
$34.60 /

-0.04 (-0.12%)

05/05/22 BMO Capital
Brinker price target lowered to $48 from $60 at BMO Capital
05/05/22 Deutsche Bank
Brinker price target lowered to $41 from $44 at Deutsche Bank
05/05/22 Barclays
Brinker price target lowered to $37 from $44 at Barclays
05/05/22 Evercore ISI
Brinker downgraded to In Line from Outperform at Evercore ISI
TUP Tupperware Brands
$10.60 /

-1.555 (-12.79%)

05/05/22 DA Davidson
DA Davidson cuts Tupperware Brands to Neutral as macro and execution weigh on Q1
05/05/22 DA Davidson
Tupperware Brands downgraded to Neutral from Buy at DA Davidson
05/05/22 Citi
Tupperware Brands downgraded to Neutral from Buy at Citi
02/28/22 Citi
Tupperware Brands price target lowered to $26 from $30 at Citi
CMLS Cumulus Media
$15.38 /

+1.17 (+8.23%)

05/05/22 Barrington
Cumulus Media initiated with an Outperform at Barrington
02/24/22 B. Riley
Cumulus Media price target raised to $26 from $23 at B. Riley
09/24/21 B. Riley
Cumulus Media price target raised to $28 from $22 at B. Riley
06/29/21 B. Riley
Cumulus Media price target raised to $22 from $18 at B. Riley
ICPT Intercept
$19.48 /

+3.28 (+20.25%)

03/08/22 Canaccord
Intercept price target lowered to $29 from $31 at Canaccord
01/11/22 B. Riley
B. Riley upgrades Intercept into 'catalyst rich' first half of 2022
01/10/22 B. Riley
Intercept upgraded to Buy from Neutral at B. Riley
12/20/21 H.C. Wainwright
Intercept delay for NASH data not due to adverse findings, says H.C. Wainwright
SLQT SelectQuote
$2.61 /

+0.2 (+8.30%)

05/05/22 Piper Sandler
SelectQuote price target lowered to $3 from $4 at Piper Sandler
04/12/22 Evercore ISI
SelectQuote added to 'TAP Underperform' list at Evercore ISI
03/31/22 Credit Suisse
SelectQuote assumed with a Neutral at Credit Suisse
02/08/22 RBC Capital
SelectQuote price target lowered to $3 from $13 at RBC Capital
HDSN Hudson Technologies
$9.05 /

+1.925 (+27.02%)

03/09/22 Roth Capital
Roth Capital upgrades Hudson Technologies to Buy, raises target to $6.50
03/09/22 Roth Capital
Hudson Technologies upgraded to Buy from Neutral at Roth Capital
05/06/21 Craig-Hallum
Hudson Technologies upgraded to Buy from Hold at Craig-Hallum
LICY Li-Cycle
$7.75 /

+0.565 (+7.86%)

04/07/22 Citi
Li-Cycle price target lowered to $10 from $11 at Citi
02/10/22 Morgan Stanley
Li-Cycle downgraded to Equal Weight from Overweight at Morgan Stanley
01/11/22 Piper Sandler
Li-Cycle price target lowered to $15 from $18 at Piper Sandler
12/01/21 BMO Capital
GM shift into cathode production positive for Li-Cycle, says BMO Capital
GLNCY Glencore
$11.95 /

-0.45 (-3.63%)

05/03/22 Morgan Stanley
Glencore price target lowered to 620 GBp from 623 GBp at Morgan Stanley
04/29/22 JPMorgan
Glencore price target raised to ZAR 13,200 from ZAR 12,400 at JPMorgan
04/05/22 Deutsche Bank
Glencore price target raised to 590 GBp from 580 GBp at Deutsche Bank
03/24/22 Morgan Stanley
Glencore price target raised to 623 GBp from 450 GBp at Morgan Stanley
FSLY Fastly
$13.80 /

-3.01 (-17.91%)

05/05/22 Morgan Stanley
Fastly price target lowered to $18 from $25 at Morgan Stanley
04/01/22 Raymond James
Fastly's FY guidance may prove conservative, says Raymond James
03/22/22 BofA
Fastly price target lowered to $16 from $28 at BofA
02/18/22 Raymond James
Raymond James upgrades Fastly to Strong Buy on share 'overreaction'
INSG Inseego
$2.31 /

-0.75 (-24.55%)

03/02/22 Canaccord
Inseego upgraded to Buy at Canaccord on valuation
03/02/22 Canaccord
Inseego upgraded to Buy from Hold at Canaccord
05/06/21 Lake Street
Inseego price target lowered to $9 from $13 at Lake Street
ETSY Etsy
$90.93 /

-18.735 (-17.08%)

05/05/22 Oppenheimer
Etsy price target lowered to $140 from $175 at Oppenheimer
05/05/22 Stifel
Etsy price target lowered to $130 from $160 at Stifel
05/05/22 Needham
Etsy price target lowered to $150 from $280 at Needham
05/05/22 DA Davidson
Etsy price target lowered to $185 from $275 at DA Davidson
CROX Crocs
$65.62 /

-6.64 (-9.19%)

04/28/22 Wedbush
Wedbush starts Crocs at Outperform on 'drastically over-done' selloff
04/28/22 Wedbush
Crocs initiated with an Outperform at Wedbush
04/06/22 Piper Sandler
Piper lists winners and losers from semi-annual teen survey
04/04/22 Loop Capital
Crocs downgraded to Hold from Buy at Loop Capital
TWLO Twilio
$116.84 /

-1.68 (-1.42%)

05/05/22 BTIG
Twilio price target lowered to $230 from $270 at BTIG
05/05/22 JMP Securities
Twilio price target lowered to $250 from $510 at JMP Securities
05/05/22 Canaccord
Twilio price target lowered to $245 from $455 at Canaccord
05/05/22 Needham
Twilio price target lowered to $200 from $350 at Needham
W Wayfair
$67.42 /

-23.26 (-25.65%)

05/05/22 Piper Sandler
Wayfair downgraded to Neutral from Overweight at Piper Sandler
05/05/22 Gordon Haskett
Wayfair downgraded to Reduce at Gordon Haskett after 'disappointing' Q1
05/05/22 Gordon Haskett
Wayfair downgraded to Reduce from Hold at Gordon Haskett
05/04/22 Cowen
Wayfair price target lowered to $220 from $275 at Cowen
K Kellogg
$70.24 /

+2.39 (+3.52%)

05/03/22 Piper Sandler
Kellogg downgraded to Underweight from Neutral at Piper Sandler
04/25/22 Deutsche Bank
Kellogg downgraded to Hold from Buy at Deutsche Bank
03/30/22 UBS
Kellogg initiated with a Buy at UBS
02/11/22 JPMorgan
Kellogg downgraded to Underweight from Neutral at JPMorgan
ZETA Zeta Global
$8.64 /

-1.765 (-16.97%)

W Wayfair
$67.42 /

-23.26 (-25.65%)

TWTR Twitter
$50.44 /

+1.34 (+2.73%)

TWLO Twilio
$116.84 /

-1.68 (-1.42%)

TUP Tupperware Brands
$10.60 /

-1.555 (-12.79%)

TSLA Tesla
$873.41 /

-79.31 (-8.32%)

SLQT SelectQuote
$2.61 /

+0.2 (+8.30%)

SIMO Silicon Motion
$95.08 /

+13.9602 (+17.21%)

SHOP Shopify
$413.51 /

-72.105 (-14.85%)

SFM Sprouts Farmers Market
$23.74 /

-7.665 (-24.41%)

MXL MaxLinear
$44.55 /

-9.04 (-16.87%)

LICY Li-Cycle
$7.75 /

+0.565 (+7.86%)

LGF.A Lionsgate
$13.49 /

-0.39 (-2.81%)

K Kellogg
$70.24 /

+2.39 (+3.52%)

INSG Inseego
$2.31 /

-0.75 (-24.55%)

ICPT Intercept
$19.48 /

+3.28 (+20.25%)

HDSN Hudson Technologies
$9.05 /

+1.925 (+27.02%)

FTNT Fortinet
$285.32 /

-1.02 (-0.36%)

FSLY Fastly
$13.80 /

-3.01 (-17.91%)

ETSY Etsy
$90.93 /

-18.735 (-17.08%)

EBAY eBay
$48.05 /

-6.37 (-11.71%)

EAT Brinker
$34.60 /

-0.04 (-0.12%)

CROX Crocs
$65.62 /

-6.64 (-9.19%)

CNC Centene
$84.71 /

+1.84 (+2.22%)

CMLS Cumulus Media
$15.38 /

+1.17 (+8.23%)

BKNG Booking Holdings
$2,173.00 /

+78.65 (+3.76%)

BHC Bausch Health
$16.76 /

-1.345 (-7.43%)

  • 06
    May
  • 10
    Jun
ZETA Zeta Global
$8.64 /

-1.765 (-16.97%)

VIVHY Vivendi
$11.58 /

-0.47 (-3.90%)

TWTR Twitter
$50.44 /

+1.34 (+2.73%)

TSLA Tesla
$873.41 /

-79.31 (-8.32%)

SHOP Shopify
$413.51 /

-72.105 (-14.85%)

SGLY Singularity Future Technology
$4.80 /

-1.96 (-28.99%)

LICY Li-Cycle
$7.75 /

+0.565 (+7.86%)

LGF.A Lionsgate
$13.49 /

-0.39 (-2.81%)

K Kellogg
$70.24 /

+2.39 (+3.52%)

GLNCY Glencore
$11.95 /

-0.45 (-3.63%)

FTNT Fortinet
$285.32 /

-1.02 (-0.36%)

ETSY Etsy
$90.93 /

-18.735 (-17.08%)

EBAY eBay
$48.05 /

-6.37 (-11.71%)

EAT Brinker
$34.60 /

-0.04 (-0.12%)

CNC Centene
$84.71 /

+1.84 (+2.22%)

CMLS Cumulus Media
$15.38 /

+1.17 (+8.23%)

BLCO Bausch + Lomb
/

+

BKNG Booking Holdings
$2,173.00 /

+78.65 (+3.76%)

BHC Bausch Health
$16.76 /

-1.345 (-7.43%)

ZETA Zeta Global
$8.64 /

-1.765 (-16.97%)

W Wayfair
$67.42 /

-23.26 (-25.65%)

TWTR Twitter
$50.44 /

+1.34 (+2.73%)

TSLA Tesla
$873.41 /

-79.31 (-8.32%)

SLQT SelectQuote
$2.61 /

+0.2 (+8.30%)

SIMO Silicon Motion
$95.08 /

+13.9602 (+17.21%)

SHOP Shopify
$413.51 /

-72.105 (-14.85%)

SGLY Singularity Future Technology
$4.80 /

-1.96 (-28.99%)

LICY Li-Cycle
$7.75 /

+0.565 (+7.86%)

LGF.A Lionsgate
$13.49 /

-0.39 (-2.81%)

ICPT Intercept
$19.48 /

+3.28 (+20.25%)

GLNCY Glencore
$11.95 /

-0.45 (-3.63%)

FSLY Fastly
$13.80 /

-3.01 (-17.91%)

CROX Crocs
$65.62 /

-6.64 (-9.19%)

CNC Centene
$84.71 /

+1.84 (+2.22%)

CMLS Cumulus Media
$15.38 /

+1.17 (+8.23%)

BLCO Bausch + Lomb
/

+

BKNG Booking Holdings
$2,173.00 /

+78.65 (+3.76%)

BHC Bausch Health
$16.76 /

-1.345 (-7.43%)

W Wayfair
$67.42 /

-23.26 (-25.65%)

TWTR Twitter
$50.44 /

+1.34 (+2.73%)

TWLO Twilio
$116.84 /

-1.68 (-1.42%)

TSLA Tesla
$873.41 /

-79.31 (-8.32%)

SLQT SelectQuote
$2.61 /

+0.2 (+8.30%)

SIMO Silicon Motion
$95.08 /

+13.9602 (+17.21%)

SHOP Shopify
$413.51 /

-72.105 (-14.85%)

SGLY Singularity Future Technology
$4.80 /

-1.96 (-28.99%)

SFM Sprouts Farmers Market
$23.74 /

-7.665 (-24.41%)

LICY Li-Cycle
$7.75 /

+0.565 (+7.86%)

K Kellogg
$70.24 /

+2.39 (+3.52%)

FTNT Fortinet
$285.32 /

-1.02 (-0.36%)

FSLY Fastly
$13.80 /

-3.01 (-17.91%)

ETSY Etsy
$90.93 /

-18.735 (-17.08%)

EBAY eBay
$48.05 /

-6.37 (-11.71%)

CROX Crocs
$65.62 /

-6.64 (-9.19%)

CNC Centene
$84.71 /

+1.84 (+2.22%)

BKNG Booking Holdings
$2,173.00 /

+78.65 (+3.76%)

BHC Bausch Health
$16.76 /

-1.345 (-7.43%)

On The Fly
What You Missed On Wall Street This Morning » 12:23
05/05/22
05/05
12:23
05/05/22
12:23
FTNT

Fortinet

$284.00 /

-2.34 (-0.82%)

, SFM

Sprouts Farmers Market

$23.86 /

-7.545 (-24.02%)

, EAT

Brinker

$34.97 /

+0.325 (+0.94%)

, TUP

Tupperware Brands

$10.51 /

-1.645 (-13.53%)

, CMLS

Cumulus Media

$15.30 /

+1.09 (+7.67%)

, BKNG

Booking Holdings

$2,193.28 /

+98.93 (+4.72%)

, EBAY

eBay

$48.75 /

-5.665 (-10.41%)

, SHOP

Shopify

$402.80 /

-82.815 (-17.05%)

, CNC

Centene

$82.71 /

-0.16 (-0.19%)

, MXL

MaxLinear

$44.14 /

-9.45 (-17.63%)

, SIMO

Silicon Motion

$96.54 /

+15.42 (+19.01%)

, TWTR

Twitter

$50.73 /

+1.625 (+3.31%)

, TSLA

Tesla

$881.20 /

-71.52 (-7.51%)

, SGLY

Singularity Future Technology

$4.76 /

-2 (-29.59%)

, ZETA

Zeta Global

$8.68 /

-1.72 (-16.54%)

, FB

Ticker changed to META

$208.72 /

-14.69 (-6.58%)

, VZ

Verizon

$47.81 /

-0.55 (-1.14%)

, ICPT

Intercept

$18.98 /

+2.78 (+17.16%)

, SLQT

SelectQuote

$2.69 /

+0.275 (+11.41%)

, HDSN

Hudson Technologies

$8.33 /

+1.205 (+16.91%)

, LICY

Li-Cycle

$7.64 /

+0.455 (+6.33%)

, FSLY

Fastly

$13.85 /

-2.96 (-17.61%)

, INSG

Inseego

$2.29 /

-0.765 (-25.04%)

, ETSY

Etsy

$90.50 /

-19.165 (-17.48%)

, CROX

Crocs

$67.20 /

-5.06 (-7.00%)

, TWLO

Twilio

$114.50 /

-4.02 (-3.39%)

, W

Wayfair

$72.11 /

-18.57 (-20.48%)

, K

Kellogg

$70.49 /

+2.64 (+3.89%)

Get caught up quickly on…

ShowHide Related Items >><<
ZETA Zeta Global
$8.68 /

-1.72 (-16.54%)

W Wayfair
$72.11 /

-18.57 (-20.48%)

VZ Verizon
$47.81 /

-0.55 (-1.14%)

TWTR Twitter
$50.73 /

+1.625 (+3.31%)

TWLO Twilio
$114.50 /

-4.02 (-3.39%)

TUP Tupperware Brands
$10.51 /

-1.645 (-13.53%)

TSLA Tesla
$881.20 /

-71.52 (-7.51%)

SLQT SelectQuote
$2.69 /

+0.275 (+11.41%)

SIMO Silicon Motion
$96.54 /

+15.42 (+19.01%)

SHOP Shopify
$402.80 /

-82.815 (-17.05%)

SGLY Singularity Future Technology
$4.76 /

-2 (-29.59%)

SFM Sprouts Farmers Market
$23.86 /

-7.545 (-24.02%)

MXL MaxLinear
$44.14 /

-9.45 (-17.63%)

LICY Li-Cycle
$7.64 /

+0.455 (+6.33%)

K Kellogg
$70.49 /

+2.64 (+3.89%)

ICPT Intercept
$18.98 /

+2.78 (+17.16%)

HDSN Hudson Technologies
$8.33 /

+1.205 (+16.91%)

FTNT Fortinet
$284.00 /

-2.34 (-0.82%)

FSLY Fastly
$13.85 /

-2.96 (-17.61%)

FB Ticker changed to META
$208.72 /

-14.69 (-6.58%)

ETSY Etsy
$90.50 /

-19.165 (-17.48%)

EBAY eBay
$48.75 /

-5.665 (-10.41%)

EAT Brinker
$34.97 /

+0.325 (+0.94%)

CROX Crocs
$67.20 /

-5.06 (-7.00%)

CNC Centene
$82.71 /

-0.16 (-0.19%)

CMLS Cumulus Media
$15.30 /

+1.09 (+7.67%)

BKNG Booking Holdings
$2,193.28 /

+98.93 (+4.72%)

FTNT Fortinet
$284.00 /

-2.34 (-0.82%)

05/05/22 Wedbush
Fortinet price target lowered to $340 from $370 at Wedbush
05/05/22 Deutsche Bank
Fortinet price target raised to $320 from $250 at Deutsche Bank
05/05/22 Wells Fargo
Fortinet price target raised to $400 from $360 at Wells Fargo
05/05/22 Mizuho
Fortinet upgraded to Buy after 'very good' quarter at Mizuho
SFM Sprouts Farmers Market
$23.86 /

-7.545 (-24.02%)

05/05/22 BofA
BofA double downgrades Sprouts to sell on price hikes, inflation
05/05/22 BofA
Sprouts Farmers Market downgraded to Underperform from Buy at BofA
04/29/22 BofA
Sprouts Farmers Market double upgraded to Buy at BofA on EPS upside
04/29/22 BofA
Sprouts Farmers Market upgraded to Buy from Underperform at BofA
EAT Brinker
$34.97 /

+0.325 (+0.94%)

05/05/22 BMO Capital
Brinker price target lowered to $48 from $60 at BMO Capital
05/05/22 Deutsche Bank
Brinker price target lowered to $41 from $44 at Deutsche Bank
05/05/22 Barclays
Brinker price target lowered to $37 from $44 at Barclays
05/05/22 Evercore ISI
Brinker downgraded to In Line from Outperform at Evercore ISI
TUP Tupperware Brands
$10.51 /

-1.645 (-13.53%)

05/05/22 DA Davidson
DA Davidson cuts Tupperware Brands to Neutral as macro and execution weigh on Q1
05/05/22 DA Davidson
Tupperware Brands downgraded to Neutral from Buy at DA Davidson
05/05/22 Citi
Tupperware Brands downgraded to Neutral from Buy at Citi
02/28/22 Citi
Tupperware Brands price target lowered to $26 from $30 at Citi
CMLS Cumulus Media
$15.30 /

+1.09 (+7.67%)

05/05/22 Barrington
Cumulus Media initiated with an Outperform at Barrington
02/24/22 B. Riley
Cumulus Media price target raised to $26 from $23 at B. Riley
09/24/21 B. Riley
Cumulus Media price target raised to $28 from $22 at B. Riley
06/29/21 B. Riley
Cumulus Media price target raised to $22 from $18 at B. Riley
BKNG Booking Holdings
$2,193.28 /

+98.93 (+4.72%)

05/05/22 Piper Sandler
Booking Holdings price target raised to $2,500 from $2,440 at Piper Sandler
05/05/22 RBC Capital
Booking Holdings price target raised to $2,800 from $2,700 at RBC Capital
05/05/22 Evercore ISI
Booking Holdings price target raised to $3,000 from $2,900 at Evercore ISI
05/05/22 Credit Suisse
Booking Holdings price target raised to $2,985 from $2,850 at Credit Suisse
EBAY eBay
$48.75 /

-5.665 (-10.41%)

05/05/22 Baird
eBay price target lowered to $65 from $80 at Baird
05/05/22 Stifel
eBay price target lowered to $62 from $70 at Stifel
05/05/22 Benchmark
eBay price target lowered to $67 from $71 at Benchmark
05/05/22 Deutsche Bank
eBay price target lowered to $60 from $64 at Deutsche Bank
SHOP Shopify
$402.80 /

-82.815 (-17.05%)

05/05/22 Jefferies
Shopify Q1 results 'worse than feared,' says Jefferies
05/05/22 Veritas
Shopify downgraded to Sell from Buy at Veritas (yesterday)
05/03/22 Loop Capital
Shopify price target lowered to $460 from $660 at Loop Capital
05/03/22 Wedbush
Shopify price target lowered to $630 from $937 at Wedbush
CNC Centene
$82.71 /

-0.16 (-0.19%)

03/29/22 Deutsche Bank
CVS Health downgraded to Hold from Buy at Deutsche Bank
03/23/22 BTIG
Exagen price target lowered to $15 from $20 at BTIG
03/23/22 Jefferies
Centene CEO pick may spur some negative stock reaction, says Jefferies
02/09/22 Deutsche Bank
Centene price target raised to $88 from $84 at Deutsche Bank
MXL MaxLinear
$44.14 /

-9.45 (-17.63%)

05/05/22 Roth Capital
Silicon Motion downgraded to Neutral from Buy at Roth Capital
04/29/22 Susquehanna
MaxLinear price target lowered to $58 from $70 at Susquehanna
04/28/22 Needham
MaxLinear price target lowered to $65 from $80 at Needham
04/28/22 Wells Fargo
Wells Fargo upgrades MaxLinear to Overweight with $66 price target
SIMO Silicon Motion
$96.54 /

+15.42 (+19.01%)

04/11/22 B. Riley
Silicon Motion price target lowered to $106 from $135 at B. Riley
01/28/22 Cowen
Silicon Motion price target raised to $110 from $105 at Cowen
01/28/22 B. Riley
Silicon Motion price target raised to $135 from $130 at B. Riley
TWTR Twitter
$50.73 /

+1.625 (+3.31%)

05/05/22 Argus
Twitter downgraded to Hold at Argus after board approves Musk buyout
05/05/22 Argus
Twitter downgraded to Hold from Buy at Argus
04/29/22 Evercore ISI
Evercore 'impressed' by Snap's product innovation after partner summit
04/28/22 Piper Sandler
Twitter price target raised to $51.50 from $46 at Piper Sandler
TSLA Tesla
$881.20 /

-71.52 (-7.51%)

04/27/22 Wedbush
Twitter transaction 'was never ideal' for Tesla investors, says Wedbush
04/26/22 Wedbush
'Soap opera' now ends with Musk owning Twitter, says Wedbush
04/25/22 Gordon Haskett
Twitter bid more attractive after market selloff, says Gordon Haskett
04/25/22 Wedbush
Twitter bid unlikely to result in major sale of Musk's Tesla stock, says Wedbush
SGLY Singularity Future Technology
$4.76 /

-2 (-29.59%)

ZETA Zeta Global
$8.68 /

-1.72 (-16.54%)

04/07/22 Oppenheimer
Zeta Global upgraded to Outperform from Perform at Oppenheimer
02/07/22 Craig-Hallum
Craig-Hallum bullish on Zeta Global, initiates with a Buy
02/07/22 Craig-Hallum
Zeta Global initiated with a Buy at Craig-Hallum
11/16/21 Credit Suisse
Zeta Global initiated with a Neutral at Credit Suisse
FB Ticker changed to META
$208.72 /

-14.69 (-6.58%)

04/28/22 MKM Partners
Meta Platforms price target lowered to $295 from $315 at MKM Partners
04/28/22 Evercore ISI
Meta Platforms price target lowered to $325 from $350 at Evercore ISI
04/28/22 Oppenheimer
Oppenheimer maintains Outperform, $305 target on Meta Platforms after Q1 results
04/28/22 Credit Suisse
Credit Suisse raises Meta Platforms price target to $273 after quarterly results
VZ Verizon
$47.81 /

-0.55 (-1.14%)

05/05/22 Northland
Casa Systems price target lowered to $6 from $10 at Northland
04/29/22 DZ Bank
Verizon downgraded to Sell from Hold at DZ Bank
04/25/22 Goldman Sachs
Verizon downgraded to Neutral from Buy at Goldman Sachs
04/19/22 Northland
Casa Systems upgraded to Outperform from Market Perform at Northland
ICPT Intercept
$18.98 /

+2.78 (+17.16%)

03/08/22 Canaccord
Intercept price target lowered to $29 from $31 at Canaccord
01/11/22 B. Riley
B. Riley upgrades Intercept into 'catalyst rich' first half of 2022
01/10/22 B. Riley
Intercept upgraded to Buy from Neutral at B. Riley
12/20/21 H.C. Wainwright
Intercept delay for NASH data not due to adverse findings, says H.C. Wainwright
SLQT SelectQuote
$2.69 /

+0.275 (+11.41%)

04/12/22 Evercore ISI
SelectQuote added to 'TAP Underperform' list at Evercore ISI
03/31/22 Credit Suisse
SelectQuote assumed with a Neutral at Credit Suisse
02/08/22 RBC Capital
SelectQuote price target lowered to $3 from $13 at RBC Capital
02/08/22 Barclays
SelectQuote price target lowered to $5 from $9 at Barclays
HDSN Hudson Technologies
$8.33 /

+1.205 (+16.91%)

03/09/22 Roth Capital
Roth Capital upgrades Hudson Technologies to Buy, raises target to $6.50
03/09/22 Roth Capital
Hudson Technologies upgraded to Buy from Neutral at Roth Capital
05/06/21 Craig-Hallum
Hudson Technologies upgraded to Buy from Hold at Craig-Hallum
LICY Li-Cycle
$7.64 /

+0.455 (+6.33%)

04/07/22 Citi
Li-Cycle price target lowered to $10 from $11 at Citi
02/10/22 Morgan Stanley
Li-Cycle downgraded to Equal Weight from Overweight at Morgan Stanley
01/11/22 Piper Sandler
Li-Cycle price target lowered to $15 from $18 at Piper Sandler
12/01/21 BMO Capital
GM shift into cathode production positive for Li-Cycle, says BMO Capital
FSLY Fastly
$13.85 /

-2.96 (-17.61%)

05/05/22 Morgan Stanley
Fastly price target lowered to $18 from $25 at Morgan Stanley
04/01/22 Raymond James
Fastly's FY guidance may prove conservative, says Raymond James
03/22/22 BofA
Fastly price target lowered to $16 from $28 at BofA
02/18/22 Raymond James
Raymond James upgrades Fastly to Strong Buy on share 'overreaction'
INSG Inseego
$2.29 /

-0.765 (-25.04%)

03/02/22 Canaccord
Inseego upgraded to Buy at Canaccord on valuation
03/02/22 Canaccord
Inseego upgraded to Buy from Hold at Canaccord
05/06/21 Lake Street
Inseego price target lowered to $9 from $13 at Lake Street
ETSY Etsy
$90.50 /

-19.165 (-17.48%)

05/05/22 Oppenheimer
Etsy price target lowered to $140 from $175 at Oppenheimer
05/05/22 Stifel
Etsy price target lowered to $130 from $160 at Stifel
05/05/22 Needham
Etsy price target lowered to $150 from $280 at Needham
05/05/22 DA Davidson
Etsy price target lowered to $185 from $275 at DA Davidson
CROX Crocs
$67.20 /

-5.06 (-7.00%)

04/28/22 Wedbush
Wedbush starts Crocs at Outperform on 'drastically over-done' selloff
04/28/22 Wedbush
Crocs initiated with an Outperform at Wedbush
04/06/22 Piper Sandler
Piper lists winners and losers from semi-annual teen survey
04/04/22 Loop Capital
Crocs downgraded to Hold from Buy at Loop Capital
TWLO Twilio
$114.50 /

-4.02 (-3.39%)

05/05/22 BTIG
Twilio price target lowered to $230 from $270 at BTIG
05/05/22 JMP Securities
Twilio price target lowered to $250 from $510 at JMP Securities
05/05/22 Canaccord
Twilio price target lowered to $245 from $455 at Canaccord
05/05/22 Needham
Twilio price target lowered to $200 from $350 at Needham
W Wayfair
$72.11 /

-18.57 (-20.48%)

05/05/22 Gordon Haskett
Wayfair downgraded to Reduce at Gordon Haskett after 'disappointing' Q1
05/05/22 Gordon Haskett
Wayfair downgraded to Reduce from Hold at Gordon Haskett
05/04/22 Cowen
Wayfair price target lowered to $220 from $275 at Cowen
04/26/22 Wedbush
Wayfair price target lowered to $85 from $140 at Wedbush
K Kellogg
$70.49 /

+2.64 (+3.89%)

05/03/22 Piper Sandler
Kellogg downgraded to Underweight from Neutral at Piper Sandler
04/25/22 Deutsche Bank
Kellogg downgraded to Hold from Buy at Deutsche Bank
03/30/22 UBS
Kellogg initiated with a Buy at UBS
02/11/22 JPMorgan
Kellogg downgraded to Underweight from Neutral at JPMorgan
ZETA Zeta Global
$8.68 /

-1.72 (-16.54%)

W Wayfair
$72.11 /

-18.57 (-20.48%)

VZ Verizon
$47.81 /

-0.55 (-1.14%)

TWTR Twitter
$50.73 /

+1.625 (+3.31%)

TWLO Twilio
$114.50 /

-4.02 (-3.39%)

TUP Tupperware Brands
$10.51 /

-1.645 (-13.53%)

TSLA Tesla
$881.20 /

-71.52 (-7.51%)

SLQT SelectQuote
$2.69 /

+0.275 (+11.41%)

SIMO Silicon Motion
$96.54 /

+15.42 (+19.01%)

SHOP Shopify
$402.80 /

-82.815 (-17.05%)

SFM Sprouts Farmers Market
$23.86 /

-7.545 (-24.02%)

MXL MaxLinear
$44.14 /

-9.45 (-17.63%)

LICY Li-Cycle
$7.64 /

+0.455 (+6.33%)

K Kellogg
$70.49 /

+2.64 (+3.89%)

INSG Inseego
$2.29 /

-0.765 (-25.04%)

ICPT Intercept
$18.98 /

+2.78 (+17.16%)

HDSN Hudson Technologies
$8.33 /

+1.205 (+16.91%)

FTNT Fortinet
$284.00 /

-2.34 (-0.82%)

FSLY Fastly
$13.85 /

-2.96 (-17.61%)

FB Ticker changed to META
$208.72 /

-14.69 (-6.58%)

ETSY Etsy
$90.50 /

-19.165 (-17.48%)

EBAY eBay
$48.75 /

-5.665 (-10.41%)

EAT Brinker
$34.97 /

+0.325 (+0.94%)

CROX Crocs
$67.20 /

-5.06 (-7.00%)

CNC Centene
$82.71 /

-0.16 (-0.19%)

CMLS Cumulus Media
$15.30 /

+1.09 (+7.67%)

BKNG Booking Holdings
$2,193.28 /

+98.93 (+4.72%)

  • 10
    Jun
ZETA Zeta Global
$8.68 /

-1.72 (-16.54%)

VZ Verizon
$47.81 /

-0.55 (-1.14%)

TWTR Twitter
$50.73 /

+1.625 (+3.31%)

TSLA Tesla
$881.20 /

-71.52 (-7.51%)

SHOP Shopify
$402.80 /

-82.815 (-17.05%)

SGLY Singularity Future Technology
$4.76 /

-2 (-29.59%)

LICY Li-Cycle
$7.64 /

+0.455 (+6.33%)

K Kellogg
$70.49 /

+2.64 (+3.89%)

FTNT Fortinet
$284.00 /

-2.34 (-0.82%)

FB Ticker changed to META
$208.72 /

-14.69 (-6.58%)

ETSY Etsy
$90.50 /

-19.165 (-17.48%)

EBAY eBay
$48.75 /

-5.665 (-10.41%)

EAT Brinker
$34.97 /

+0.325 (+0.94%)

CNC Centene
$82.71 /

-0.16 (-0.19%)

CMLS Cumulus Media
$15.30 /

+1.09 (+7.67%)

BKNG Booking Holdings
$2,193.28 /

+98.93 (+4.72%)

ZETA Zeta Global
$8.68 /

-1.72 (-16.54%)

W Wayfair
$72.11 /

-18.57 (-20.48%)

VZ Verizon
$47.81 /

-0.55 (-1.14%)

TWTR Twitter
$50.73 /

+1.625 (+3.31%)

TWLO Twilio
$114.50 /

-4.02 (-3.39%)

TSLA Tesla
$881.20 /

-71.52 (-7.51%)

SLQT SelectQuote
$2.69 /

+0.275 (+11.41%)

SIMO Silicon Motion
$96.54 /

+15.42 (+19.01%)

SHOP Shopify
$402.80 /

-82.815 (-17.05%)

SGLY Singularity Future Technology
$4.76 /

-2 (-29.59%)

SFM Sprouts Farmers Market
$23.86 /

-7.545 (-24.02%)

MXL MaxLinear
$44.14 /

-9.45 (-17.63%)

LICY Li-Cycle
$7.64 /

+0.455 (+6.33%)

K Kellogg
$70.49 /

+2.64 (+3.89%)

ICPT Intercept
$18.98 /

+2.78 (+17.16%)

FTNT Fortinet
$284.00 /

-2.34 (-0.82%)

FSLY Fastly
$13.85 /

-2.96 (-17.61%)

FB Ticker changed to META
$208.72 /

-14.69 (-6.58%)

ETSY Etsy
$90.50 /

-19.165 (-17.48%)

EBAY eBay
$48.75 /

-5.665 (-10.41%)

EAT Brinker
$34.97 /

+0.325 (+0.94%)

CROX Crocs
$67.20 /

-5.06 (-7.00%)

CNC Centene
$82.71 /

-0.16 (-0.19%)

CMLS Cumulus Media
$15.30 /

+1.09 (+7.67%)

BKNG Booking Holdings
$2,193.28 /

+98.93 (+4.72%)

W Wayfair
$72.11 /

-18.57 (-20.48%)

VZ Verizon
$47.81 /

-0.55 (-1.14%)

TWTR Twitter
$50.73 /

+1.625 (+3.31%)

TWLO Twilio
$114.50 /

-4.02 (-3.39%)

TSLA Tesla
$881.20 /

-71.52 (-7.51%)

SLQT SelectQuote
$2.69 /

+0.275 (+11.41%)

SIMO Silicon Motion
$96.54 /

+15.42 (+19.01%)

SHOP Shopify
$402.80 /

-82.815 (-17.05%)

SGLY Singularity Future Technology
$4.76 /

-2 (-29.59%)

SFM Sprouts Farmers Market
$23.86 /

-7.545 (-24.02%)

LICY Li-Cycle
$7.64 /

+0.455 (+6.33%)

K Kellogg
$70.49 /

+2.64 (+3.89%)

FTNT Fortinet
$284.00 /

-2.34 (-0.82%)

FSLY Fastly
$13.85 /

-2.96 (-17.61%)

FB Ticker changed to META
$208.72 /

-14.69 (-6.58%)

ETSY Etsy
$90.50 /

-19.165 (-17.48%)

EBAY eBay
$48.75 /

-5.665 (-10.41%)

CROX Crocs
$67.20 /

-5.06 (-7.00%)

CNC Centene
$82.71 /

-0.16 (-0.19%)

BKNG Booking Holdings
$2,193.28 /

+98.93 (+4.72%)

Hot Stocks
Intercept reports Advanz to acquire Ocaliva rights outside U.S. for up to $450M » 09:50
05/05/22
05/05
09:50
05/05/22
09:50
ICPT

Intercept

$18.42 /

+2.22 (+13.70%)

Earlier, Intercept…

Earlier, Intercept Pharmaceuticals announced it has entered into an agreement to sell to Advanz Pharma, a pharmaceutical company with a strategic focus on specialty and hospital pharmaceuticals in Europe, certain foreign subsidiaries and rights regarding Intercept's international operations, including a license to commercialize Ocaliva outside of the U.S. "This agreement marks an important step forward for Intercept as the value it brings to our company allows us to significantly strengthen our balance sheet while providing us with greater strategic optionality during this transformational year and beyond," said Jerry Durso, President and Chief Executive Officer of Intercept. "We are committed to investing in our core focus areas in the U.S., including our PBC business, potential future activities in NASH, and our advancing and expanding pipeline. At the same time, we are confident that the strong international team will continue to build on our successful PBC business as they transition to Advanz Pharma." Upon closing of the transaction: Intercept will receive consideration in the amount of $405M upfront, subject to customary working capital and other adjustments. The company will receive an additional $45M from Advanz Pharma contingent upon receipt of an extension of pediatric orphan exclusivity in Europe. Intercept will receive royalties on any future net sales of obeticholic acid in NASH outside of the U.S., should Advanz Pharma pursue marketing authorization for this indication in ex-U.S. regions. Intercept will continue to be responsible for the manufacturing and supply of obeticholic acid globally and Advanz Pharma will be responsible for packaging, distribution and commercialization of the therapy in all markets outside of the U.S. The majority of Intercept employees outside of the U.S. will transfer to Advanz Pharma. The remaining international employees will continue to work for Intercept. Intercept will maintain an office in the UK to manage its global supply chain, support its quality organization, and support its global clinical trials.

ShowHide Related Items >><<
ICPT Intercept
$18.42 /

+2.22 (+13.70%)

ICPT Intercept
$18.42 /

+2.22 (+13.70%)

03/08/22 Canaccord
Intercept price target lowered to $29 from $31 at Canaccord
01/11/22 B. Riley
B. Riley upgrades Intercept into 'catalyst rich' first half of 2022
01/10/22 B. Riley
Intercept upgraded to Buy from Neutral at B. Riley
12/20/21 H.C. Wainwright
Intercept delay for NASH data not due to adverse findings, says H.C. Wainwright
ICPT Intercept
$18.42 /

+2.22 (+13.70%)

ICPT Intercept
$18.42 /

+2.22 (+13.70%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.